XBP vs NLSP
Comparison between XBP Global Holdings Inc (XBP, Company) and NLS Pharmaceutics Ltd (NLSP, Company).
XBP vs NLSP - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
XBP
$29M
NLSP
$29M
Max Drawdown
Winner
XBP
99.46%
NLSP
99.92%
Sharpe Ratio
Winner
XBP
-0.43
NLSP
-1.17
5Y Beta
XBP
0.76
NLSP
N/A
Industry
XBP
Software - Infrastructure
NLSP
N/A
P/E Ratio
XBP
-0.07
Winner
NLSP
-6.94
PEG Ratio
XBP
-0.00
NLSP
N/A
Debt to Equity
XBP
609.35%
NLSP
N/A
Free Cash Flow Yield
XBP
-5.29%
NLSP
N/A
P/S Ratio
XBP
0.04
NLSP
N/A
P/B Ratio
Winner
XBP
0.47
NLSP
10.13
XBP vs NLSP - Historical Returns
Returns include dividend reinvestment.
1M
Winner
XBP
+4.70%
NLSP
-3.00%
3M
XBP
-54.55%
Winner
NLSP
+15.77%
6M
XBP
-57.24%
Winner
NLSP
+11.00%
1Y
Winner
XBP
-75.00%
NLSP
-86.49%
5Y(CAGR)
XBP
N/A
NLSP
-70.14%
Max(CAGR)
XBP
-81.01%
Winner
NLSP
-66.57%
XBP vs NLSP - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | XBP | NLSP |
|---|---|---|
| 2026 | -65.49% | +54.55% |
| 2025 | -35.75% | -91.28% |
| 2024 | -80.15% | -91.03% |
| 2023 | -67.92% | -57.86% |
| 2022 | N/A | +8.40% |
| 2021 | N/A | -61.59% |
XBP vs NLSP Drawdown Comparison
The maximum drawdown for XBP was -99.46%, occurring on May 18, 2026. This drawdown has not yet recovered.
The maximum drawdown for NLSP was -99.92%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The current XBP drawdown is -99.36%. The current NLSP drawdown is -99.86%.
| Rank | XBP | NLSP |
|---|---|---|
| #1 | -99.46% Dec 4, 2023 - May 18, 2026 | -99.92% Mar 12, 2021 - Mar 30, 2026 |
| #2 | N/A | -35.41% Feb 11, 2021 - Mar 12, 2021 |
| #3 | N/A | -9.34% Jan 29, 2021 - Feb 3, 2021 |
| #4 | N/A | -7.69% Feb 4, 2021 - Feb 11, 2021 |
Correlation
Correlation between XBP and NLSP is 0.58 which considered as a moderate positive correlation - the stocks show some tendency to move together.
0.58
-101
Select Stocks to Compare
Popular: XBP vs SPYNLSP vs SPY
More Comparisons
Compare with similar stocks